Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.


Subscribe or Register

Existing user? Login


Global health

Access to HIV drugs rises across the world, says UNAIDS

Michel Sidibé, executive director of UNAIDS

Source: UNAIDS

Michel Sidibé, the executive director of UNAIDS, says that although the progress we have made with HIV cases is remarkable, if we do not act now we risk resurgence and resistance in the future

The number of people in the world with HIV who gained access to antiretroviral treatment in the past six months has risen by one million, according to a report published by the international charity UNAIDS on 21 November 2016.

There are now 18.2 million people receiving the therapy – double the number of people five years ago, the report points out.

And if current access to drug trends continue, the world is on track to achieve the United Nation’s target to have 30 million people on appropriate HIV therapy by 2030, which would bring an end to the global AIDs epidemic.

Launching the report, Michel Sidibé, the executive director of UNAIDS, says: “The progress we have made is remarkable, particularly around treatment, but it is also incredibly fragile. New threats are emerging and if we do not act now we risk resurgence and resistance. We have seen this with TB. We must not make the same mistakes again.”

The report also warns that despite the overall increases in access to medicines, new HIV infections are continuing to rise in some patient populations. Between 2010 and 2015, there was a 36% increase in HIV infections among people who inject drugs and a 12% rise in the number of infected homosexual men and men who have sex with men.

In 2015, the total number of people newly infected with AIDS globally was 2.1 million, of which 110,000 were children aged under 15 years.

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2016.20201977

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • Drugs of Abuse

    Drugs of Abuse

    A concise, easy-to-read guide for healthcare professionals who encounter drug abuse.

    £38.00Buy now
  • Pharmaceutical Toxicology

    Pharmaceutical Toxicology

    Explains the methodology and requirements of pre-clinical safety assessments of new medicines. Includes registration requirements and pharmacovigilance.

    £40.00Buy now
  • Drugs and the Liver

    Drugs and the Liver

    Drugs and the Liver assists practitioners in making pragmatic choices for their patients. It enables you to assess liver function and covers the principles of drug use in liver disease.

    £38.00Buy now
  • Clarke's Analysis of Drugs and Poisons

    Clarke's Analysis of Drugs and Poisons

    Clarke's Analysis of Drugs and Poisons is the definitive reference source of analytical data for drugs and poisons.

    £535.00Buy now
  • Injectable Drugs Guide

    Injectable Drugs Guide

    A user friendly, single point of reference for healthcare professionals in the safe and effective administration of injectable medicines.

    £54.00Buy now
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Supplementary images

  • Michel Sidibé, executive director of UNAIDS

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.